nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone phenpropionate—AR—autistic disorder	0.524	0.544	CbGaD
Nandrolone phenpropionate—CYP19A1—autistic disorder	0.439	0.456	CbGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—DLX1—autistic disorder	0.00197	0.0646	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Tryptophan metabolism—TDO2—autistic disorder	0.0013	0.0427	CbGpPWpGaD
Nandrolone phenpropionate—Nandrolone decanoate—MAOB—autistic disorder	0.00108	0.174	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—PRLR—autistic disorder	0.00103	0.0339	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Tryptophan metabolism—ASMT—autistic disorder	0.000986	0.0323	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—JAKMIP1—autistic disorder	0.000906	0.0297	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptors—RORA—autistic disorder	0.00088	0.0289	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—GHR—autistic disorder	0.000814	0.0267	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—JAKMIP1—autistic disorder	0.00078	0.0256	CbGpPWpGaD
Nandrolone phenpropionate—Nandrolone decanoate—MAOA—autistic disorder	0.000756	0.122	CrCbGaD
Nandrolone phenpropionate—Nandrolone decanoate—AR—autistic disorder	0.000747	0.121	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Tryptophan metabolism—UBE3A—autistic disorder	0.000713	0.0234	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nuclear Receptor transcription pathway—RORA—autistic disorder	0.000695	0.0228	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone Propionate—COMT—autistic disorder	0.000686	0.111	CrCbGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—UBE3A—autistic disorder	0.000661	0.0217	CbGpPWpGaD
Nandrolone phenpropionate—Nandrolone decanoate—CYP19A1—autistic disorder	0.000626	0.101	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Tryptophan metabolism—MAOB—autistic disorder	0.000609	0.02	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—DLX2—autistic disorder	0.000569	0.0187	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone Propionate—AR—autistic disorder	0.000511	0.0827	CrCbGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—MECP2—autistic disorder	0.000507	0.0166	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—BDNF—autistic disorder	0.000503	0.0165	CbGpPWpGaD
Nandrolone phenpropionate—Levonorgestrel—AR—autistic disorder	0.000497	0.0804	CrCbGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—UBE3A—autistic disorder	0.000488	0.016	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—HTR3A—autistic disorder	0.000431	0.0141	CbGpPWpGaD
Nandrolone phenpropionate—Levonorgestrel—CYP19A1—autistic disorder	0.000416	0.0673	CrCbGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—TSC2—autistic disorder	0.000404	0.0133	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—MAOB—autistic disorder	0.000399	0.0131	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Endogenous sterols—POMC—autistic disorder	0.000386	0.0127	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—NTF3—autistic disorder	0.000367	0.012	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—C4B—autistic disorder	0.000367	0.012	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—GABRA1—autistic disorder	0.000352	0.0115	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTM5—autistic disorder	0.000343	0.0113	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—GSTM5—autistic disorder	0.000338	0.0111	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Tryptophan metabolism—CAT—autistic disorder	0.000332	0.0109	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CHRNA7—autistic disorder	0.000327	0.0107	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—IL5—autistic disorder	0.000317	0.0104	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—autistic disorder	0.000289	0.00949	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—RORA—autistic disorder	0.000284	0.00933	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—SLC1A3—autistic disorder	0.000278	0.00912	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—AQP4—autistic disorder	0.000278	0.00912	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—NF1—autistic disorder	0.000273	0.00897	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—TPH2—autistic disorder	0.000248	0.00813	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—NF1—autistic disorder	0.000235	0.00772	CbGpPWpGaD
Nandrolone phenpropionate—Progesterone—AR—autistic disorder	0.000235	0.038	CrCbGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CHRNB2—autistic disorder	0.000235	0.0077	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—IL10—autistic disorder	0.000232	0.00761	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—MEF2C—autistic disorder	0.000226	0.0074	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—MAOA—autistic disorder	0.000224	0.0363	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—MAOA—autistic disorder	0.000223	0.00732	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—AR—autistic disorder	0.000222	0.0359	CrCbGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL13—autistic disorder	0.000219	0.0072	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CHRNA4—autistic disorder	0.000213	0.00699	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—MAOB—autistic disorder	0.000212	0.00696	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—TF—autistic disorder	0.000211	0.00691	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—TSC1—autistic disorder	0.000203	0.00667	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—MAPK1—autistic disorder	0.0002	0.00656	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—SLC6A4—autistic disorder	0.000198	0.0065	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—NTRK2—autistic disorder	0.000193	0.00632	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—MAPK1—autistic disorder	0.000192	0.0063	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL1RN—autistic disorder	0.000192	0.00629	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—IGFBP3—autistic disorder	0.000188	0.00616	CbGpPWpGaD
Nandrolone phenpropionate—Testosterone—CYP19A1—autistic disorder	0.000186	0.03	CrCbGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—autistic disorder	0.000179	0.00588	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—TSC1—autistic disorder	0.000175	0.00574	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—autistic disorder	0.000174	0.00571	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CYP19A1—autistic disorder	0.000166	0.00544	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—DHCR7—autistic disorder	0.000163	0.00536	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—HRAS—autistic disorder	0.00016	0.00526	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—GJA1—autistic disorder	0.000158	0.00519	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—CARS—autistic disorder	0.000153	0.00501	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—CARS2—autistic disorder	0.000153	0.00501	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—autistic disorder	0.00015	0.00491	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—MAOA—autistic disorder	0.000149	0.00489	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—AVP—autistic disorder	0.000146	0.00479	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—POMC—autistic disorder	0.000145	0.00477	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—BDNF—autistic disorder	0.000144	0.00472	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—AR—autistic disorder	0.000139	0.00455	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL10—autistic disorder	0.000137	0.0045	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—MEF2C—autistic disorder	0.000134	0.00438	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—BDNF—autistic disorder	0.000122	0.00401	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—HTR2A—autistic disorder	0.000121	0.00399	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—RORA—autistic disorder	0.00012	0.00394	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—COMT—autistic disorder	0.000119	0.00392	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTP1—autistic disorder	0.000119	0.0039	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—MAOA—autistic disorder	0.000119	0.00389	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—TSC2—autistic disorder	0.000118	0.00389	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—COMT—autistic disorder	0.000118	0.00386	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—GSTP1—autistic disorder	0.000117	0.00385	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PLA2G4A—autistic disorder	0.000117	0.00383	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTM1—autistic disorder	0.000109	0.00358	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—GSTM1—autistic disorder	0.000108	0.00353	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—PTEN—autistic disorder	0.000106	0.00347	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—NPAS2—autistic disorder	0.000103	0.00339	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ACADSB—autistic disorder	0.000102	0.00335	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—INPP1—autistic disorder	0.000102	0.00335	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—TSC2—autistic disorder	0.000102	0.00334	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—MBD3—autistic disorder	9.44e-05	0.0031	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—BTD—autistic disorder	9.11e-05	0.00299	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—RORA—autistic disorder	8.69e-05	0.00285	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—APC—autistic disorder	8.67e-05	0.00284	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EGF—autistic disorder	8.57e-05	0.00281	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—TAF1C—autistic disorder	8.5e-05	0.00279	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—BCL2—autistic disorder	8.36e-05	0.00274	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—IGF1—autistic disorder	7.94e-05	0.0026	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TDO2—autistic disorder	7.74e-05	0.00254	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—POMC—autistic disorder	7.72e-05	0.00253	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—DHCR7—autistic disorder	7.28e-05	0.00239	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—autistic disorder	7.19e-05	0.00236	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—BCL2—autistic disorder	6.93e-05	0.00227	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—PTEN—autistic disorder	6.93e-05	0.00227	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—EXT1—autistic disorder	6.9e-05	0.00226	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC6A8—autistic disorder	6.9e-05	0.00226	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—DAO—autistic disorder	6.59e-05	0.00216	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—autistic disorder	6.58e-05	0.00216	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—UPB1—autistic disorder	6.31e-05	0.00207	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—autistic disorder	5.96e-05	0.00196	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTM5—autistic disorder	5.87e-05	0.00193	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ASMT—autistic disorder	5.87e-05	0.00193	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—RORA—autistic disorder	5.78e-05	0.0019	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PTEN—autistic disorder	5.74e-05	0.00188	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MAPK1—autistic disorder	5.63e-05	0.00185	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC25A12—autistic disorder	5.52e-05	0.00181	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC19A1—autistic disorder	5.37e-05	0.00176	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—RPL10—autistic disorder	5.31e-05	0.00174	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—EIF4E—autistic disorder	5.08e-05	0.00167	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—autistic disorder	4.85e-05	0.00159	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ADSL—autistic disorder	4.78e-05	0.00157	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—XDH—autistic disorder	4.69e-05	0.00154	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	4.67e-05	0.00153	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—STX1A—autistic disorder	4.61e-05	0.00151	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—NPAS2—autistic disorder	4.61e-05	0.00151	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TCN2—autistic disorder	4.45e-05	0.00146	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ADA—autistic disorder	4.24e-05	0.00139	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL6—autistic disorder	4.22e-05	0.00138	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	4.19e-05	0.00138	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	4.02e-05	0.00132	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—RORA—autistic disorder	3.87e-05	0.00127	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—SERPINE1—autistic disorder	3.74e-05	0.00123	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—MAOB—autistic disorder	3.63e-05	0.00119	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—autistic disorder	3.45e-05	0.00113	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—TPH2—autistic disorder	3.37e-05	0.00111	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—DPYD—autistic disorder	3.32e-05	0.00109	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	3.11e-05	0.00102	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CACNA1C—autistic disorder	3.08e-05	0.00101	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.96e-05	0.000973	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—DHFR—autistic disorder	2.8e-05	0.00092	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	2.36e-05	0.000776	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	2.06e-05	0.000677	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—COMT—autistic disorder	2.04e-05	0.00067	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTP1—autistic disorder	2.03e-05	0.000667	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—MAOA—autistic disorder	2.03e-05	0.000665	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CAT—autistic disorder	1.98e-05	0.000649	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PLA2G4A—autistic disorder	1.87e-05	0.000613	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTM1—autistic disorder	1.87e-05	0.000613	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—SERPINE1—autistic disorder	1.8e-05	0.000591	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GPX1—autistic disorder	1.79e-05	0.000587	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—MTHFR—autistic disorder	1.65e-05	0.000542	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—APOE—autistic disorder	1.54e-05	0.000504	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CG—autistic disorder	1.39e-05	0.000455	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—POMC—autistic disorder	1.32e-05	0.000433	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTGS2—autistic disorder	1.05e-05	0.000346	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTEN—autistic disorder	9.18e-06	0.000301	CbGpPWpGaD
